Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 7/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4763694 | 0.79 | ALDH1A1 (0.48) | ALDH1A1EPHX1ATMTSHRHPGD | |
| SCHEMBL10042967 | 0.77 | DGAT1 (0.34) | NPSR1 | |
| SCHEMBL18154488 | 0.76 | ALDH1A1 (0.45) | ALDH1A1EPHX1ATMTSHRHPGD | |
| SCHEMBL10042966 | 0.75 | GAA (0.47) | ALDH1A1EPHX1ATMTSHRHPGD | |
| SCHEMBL14007854 | 0.74 | TSHR (0.51) | ALDH1A1EPHX1ATMTSHRHPGD | |
| SCHEMBL15799852 | 0.73 | EPHX1 (0.56) | ALDH1A1EPHX1TSHRACHEHCAR2 | |
| SCHEMBL19014683 | 0.73 | EPHX1 (0.56) | ALDH1A1EPHX1TSHRACHEHCAR2 | |
| SCHEMBL6962666 | 0.72 | ALDH1A1 (0.48) | ALDH1A1EPHX1ATMTSHRHPGD | |
| Hydrochloric Acid SCHEMBL15796615 | 0.71 | EPHX1 (0.55) | ALDH1A1EPHX1TSHRACHEHCAR2 | |
| SCHEMBL15095354 | 0.71 | DGAT1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481496-B2 | Gold (III) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents | UNIVERSITA' DEGLI STUDI DI PADOVA (IT) | 2013-07-09 | — | — | US | disclosed |
| US-20120101044-A1 | GOLD (III) COMPLEXES WITH OLIGOPEPTIDES FUNCTIONALIZED WITH SULFUR DONORS AND USE THEREOF AS ANTITUMOR AGENTS | UNIVERSITA' DEGLI STUDI DI PADOVA | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101044-A1 | GOLD (III) COMPLEXES WITH OLIGOPEPTIDES FUNCTIONALIZED WITH SULFUR DONORS AND USE THEREOF AS ANTITUMOR AGENTS | UACA, UBXN4, PDIA3 | ALDH1A1 3991/4885EPHX1 4636/4885ATM 4387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.